National Health and Medical Research Council

The National Health and Medical Research Council (NHMRC) is Australia’s leading expert body promoting the development and maintenance of public and individual health standards. NHMRC brings together within a single national organisation the functions of research funding and development of advice. One of its strengths is that it draws upon the resources of all components of the health system, including governments, medical practitioners, nurses and allied health professionals, researchers, teaching and research institutions, public and private program managers, service administrators, community health organisations, social health researchers and consumers.


Proposed changes to the infant pneumococcal vaccination schedule recommendations released for public…

The Department of Health on behalf of the Australian Technical Advisory Group on Immunisation (ATAGI) has released proposed changes to the infant pneumococcal vaccination schedule recommendations for public consultation between 1 September 2017 and 2 October 2017. ATAGI will be seeking NHMRC approval of the guideline recommendations under section 14A […]


Minor Amendments to the Australian Immunisation Handbook 10th Edition

NHMRC has approved minor amendments to the Australian Immunisation Handbook 10th Edition. NHMRC CEO, Professor Kelso AO, approved these amendments under section 14A of the National Health and Medical Research Act 1992 (the Act). The Australian Immunisation Handbook provides clinical information for Australian immunisation providers on the safest and most […]


Public consultation now open on draft modules for ‘Guidelines for Guidelines’

NHMRC is pleased to introduce the first five draft modules of its ‘Guidelines for Guidelines’ series which offer practical advice on how to meet NHMRC’s Standards for Guidelines. NHMRC seeks your feedback on the first five modules: Identifying and managing conflicts of interest Engaging stakeholders Public consultation Adopt, adapt, or […]


Proposed changes to the human papillomavirus (HPV) vaccination recommendations released for public…

The Department of Health on behalf of the Australian Technical Advisory Group on Immunisation (ATAGI) has released proposed changes to the human papillomavirus (HPV) vaccination recommendations for public consultation between 30 October 2017 and 30 November 2017. ATAGI will be seeking NHMRC approval of the guideline recommendations under section 14A […]


Development Grants – seeking commercialisation expert peer reviewers

NHMRC invites individuals with experience related to the commercialisation of health and medical research to participate in the 2018 peer review of applications for the Development Grants scheme. Commercialisation assessors are expected to have a minimum of five years biotechnology, med-tech or related industry experience. The Development Grants scheme supports the […]


NHMRC approves perinatal mental health care guideline

NHMRC has recently approved the recommendations made in the updated Mental health care in the perinatal period: Australian clinical practice guideline developed by the Centre of Perinatal Excellence (COPE).  The guideline makes recommendations on prevention, screening and treatment of mental health conditions during the perinatal period (from conception to the end […]


GrantConnect – Australian Government's grants information system

What is GrantConnect? GrantConnect provides a central location for potential grant applicants to find and access Grant Opportunities and documentation on Commonwealth grant schemes. Anyone can sign up to receive optional email notification of new Commonwealth Grant Opportunities, relevant to their interests, as they are published. GrantConnect is part of […]


Updates to the Australian Immunisation Handbook 10th Edition

The CEO of NHMRC has approved updates to the Australian Immunisation Handbook 10th Edition under section 14A of the National Health and Medical Research Act 1992. The Australian Immunisation Handbook provides clinical information for Australian immunisation providers on the safest and most effective use of vaccines, new vaccines and vaccine-preventable diseases […]